Sign in

Redmile Group, LLC

CIK:0001425738
Hedge Fund
$5B AUM
48 holdings
San Francisco, CA, United States
Founded:2007
26 employees
Latest filing:Jun 30, 2025

Redmile Group, LLC is an investment management firm founded in March 2007, headquartered in San Francisco, California, with an additional office in New York. The firm specializes in investments in U.S. and non-U.S. healthcare companies, providing both hedge fund and private equity strategies. Redmile Group serves institutional and high-net-worth clients, managing assets across both public and private healthcare sectors with a focus on innovation and growth in healthcare.

Investment Strategy

Redmile Group focuses on investments in the healthcare sector, both in the U.S. and internationally, targeting innovative firms in biotechnology, pharmaceuticals, and related subsectors. The firm employs both hedge fund and private equity strategies, investing in early-stage and growth opportunities. Its philosophy emphasizes in-depth research, sector expertise, and identifying transformative healthcare trends to generate long-term value for its investors.

Top Buys
A
ADCTADC THERAPEUTICS SA
+$19.9M
S
STOKSTOKE THERAPEUTICS INC
+$19.8M
H
HNGEHINGE HEALTH INC
+$15.5M
I
IMNMIMMUNOME INC
+$9.2M
K
KYMRKYMERA THERAPEUTICS INC
+$8.1M
Top Sells
F
FOLDAMICUS THERAPEUTICS INC
-$71.0M
K
KRYSKRYSTAL BIOTECH INC
-$41.8M
B
BHVNBIOHAVEN LTD
-$10.6M
B
BSXBOSTON SCIENTIFIC CORP
-$10.3M
C
COGTCOGENT BIOSCIENCES INC
-$8.9M

Top Holdings

S
SRRKSCHOLAR ROCK HLDG CORP
+14.8%$139.2M
K
KRYSKRYSTAL BIOTECH INC
+9.7%$91.2M
Z
ZYMEZYMEWORKS INC
+5.5%$52.1M
S
STOKSTOKE THERAPEUTICS INC
+5.3%$49.7M
I
IMNMIMMUNOME INC
+4.8%$45.3M

Equity Positions (48)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
S
SRRK
SCHOLAR ROCK HLDG CORP14.81%$139.2M3,929,039$12.80$35.42-$2.2M
K
KRYS
KRYSTAL BIOTECH INC9.71%$91.2M663,471$66.33$137.46-$41.8M
Z
ZYME
ZYMEWORKS INC5.54%$52.1M4,150,627$7.92$12.55-$4.9M
S
STOK
STOKE THERAPEUTICS INC5.29%$49.7M4,375,931$11.49$11.35+$19.8M
I
IMNM
IMMUNOME INC4.82%$45.3M4,872,225$12.43$9.30+$9.2M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+51.2%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+43.3%
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
+5.3%
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
+2.3%
SERVICES-COMPUTER PROCESSING & DATA PREPARATION
+1.7%